Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN0101 in Recurrent Castration Resistant Prostate Cancer
NCT02502994Phase 1Unknown
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label trial of GEN0101 in prostate cancer (PCa). Status: unknown.
02
Drugs
GEN0101
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02502994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502994.